Lorence H. Kim Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lorence H. Kim.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lorence H. Kim. Lorence H. Kim is Director in Seres Therapeutics, Inc. ($MCRB) and Chief Financial Officer in Moderna, Inc. ($MRNA).
Latest Insider Trading Transactions of Lorence H. Kim
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 19.15 | 96,660 | 1,851,039 | 0 | |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 19.15 | 66,031 | 1,264,494 | 578,372 | |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 78,309 | 1,113,554 | 587,735 | |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 58.30 | 241,000 | 14,050,300 | 1,202,510 | 1.4 M to 1.2 M (-16.70 %) |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 19.15 | 96,660 | 1,851,039 | 1,443,510 | 1.3 M to 1.4 M (+7.18 %) |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 19.15 | 66,031 | 1,264,494 | 1,346,850 | 1.3 M to 1.3 M (+5.16 %) |
| Jun 04 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 78,309 | 1,113,554 | 1,280,819 | 1.2 M to 1.3 M (+6.51 %) |
| May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 222,365 | 3,162,030 | 666,044 | |
| May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 18,635 | 227,533 | 55,909 | |
| May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 51.13 | 241,000 | 12,322,330 | 1,202,510 | 1.4 M to 1.2 M (-16.70 %) |
| May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 18,635 | 227,533 | 1,443,510 | 1.4 M to 1.4 M (+1.31 %) |
| May 28 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 222,365 | 3,162,030 | 1,424,875 | 1.2 M to 1.4 M (+18.49 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 12.21 | 211,978 | 2,588,251 | 74,544 | |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 14.22 | 29,022 | 412,693 | 888,409 | |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.96 | 798 | 69,394 | 1,202,510 | 1.2 M to 1.2 M (-0.07 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 86.54 | 2,600 | 225,004 | 1,203,308 | 1.2 M to 1.2 M (-0.22 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 85.16 | 5,868 | 499,719 | 1,205,908 | 1.2 M to 1.2 M (-0.48 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 84.27 | 33,792 | 2,847,652 | 1,211,776 | 1.2 M to 1.2 M (-2.71 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 83.33 | 59,175 | 4,931,053 | 1,245,568 | 1.3 M to 1.2 M (-4.54 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 82.28 | 56,379 | 4,638,864 | 1,304,743 | 1.4 M to 1.3 M (-4.14 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 81.43 | 16,736 | 1,362,812 | 1,361,122 | 1.4 M to 1.4 M (-1.21 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 80.24 | 35,569 | 2,854,057 | 1,377,858 | 1.4 M to 1.4 M (-2.52 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 79.40 | 18,675 | 1,482,795 | 1,413,427 | 1.4 M to 1.4 M (-1.30 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 77.48 | 7,640 | 591,947 | 1,432,102 | 1.4 M to 1.4 M (-0.53 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 76.45 | 3,768 | 288,064 | 1,439,742 | 1.4 M to 1.4 M (-0.26 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 12.21 | 211,978 | 2,588,251 | 1,443,510 | 1.2 M to 1.4 M (+17.21 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 14.22 | 29,022 | 412,693 | 1,231,532 | 1.2 M to 1.2 M (+2.41 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.68 | 2,243 | 149,563 | 1,202,510 | 1.2 M to 1.2 M (-0.19 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 66.05 | 9,715 | 641,676 | 1,204,753 | 1.2 M to 1.2 M (-0.80 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 64.96 | 5,442 | 353,512 | 1,214,468 | 1.2 M to 1.2 M (-0.45 %) |
| May 19 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 63.80 | 2,600 | 165,880 | 1,219,910 | 1.2 M to 1.2 M (-0.21 %) |
| Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 38.24 | 400 | 15,296 | 1,222,510 | 1.2 M to 1.2 M (-0.03 %) |
| Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 37.62 | 7,340 | 276,131 | 1,222,910 | 1.2 M to 1.2 M (-0.60 %) |
| Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 36.57 | 4,566 | 166,979 | 1,230,250 | 1.2 M to 1.2 M (-0.37 %) |
| Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 35.81 | 1,517 | 54,324 | 1,234,816 | 1.2 M to 1.2 M (-0.12 %) |
| Apr 16 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 34.24 | 6,177 | 211,500 | 1,236,333 | 1.2 M to 1.2 M (-0.50 %) |
| Mar 18 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 27.39 | 1,134 | 31,060 | 1,242,510 | 1.2 M to 1.2 M (-0.09 %) |
| Mar 18 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 26.74 | 9,370 | 250,554 | 1,243,644 | 1.3 M to 1.2 M (-0.75 %) |
| Mar 18 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 25.85 | 6,704 | 173,298 | 1,253,014 | 1.3 M to 1.3 M (-0.53 %) |
| Mar 18 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 24.68 | 2,792 | 68,907 | 1,259,718 | 1.3 M to 1.3 M (-0.22 %) |
| Mar 06 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 27.71 | 20,000 | 554,200 | 1,262,510 | 1.3 M to 1.3 M (-1.56 %) |
| Mar 03 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | A | 25.93 | 179,022 | 4,642,040 | 179,022 | |
| Feb 27 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 29.46 | 745 | 21,948 | 1,282,510 | 1.3 M to 1.3 M (-0.06 %) |
| Feb 27 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 28.79 | 12,819 | 369,059 | 1,283,255 | 1.3 M to 1.3 M (-0.99 %) |
| Feb 27 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 27.96 | 5,088 | 142,260 | 1,296,074 | 1.3 M to 1.3 M (-0.39 %) |
| Feb 27 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 26.14 | 100 | 2,614 | 1,301,162 | 1.3 M to 1.3 M (-0.01 %) |
| Feb 27 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 25.59 | 1,248 | 31,936 | 1,301,262 | 1.3 M to 1.3 M (-0.10 %) |
| Feb 11 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 23.06 | 33,295 | 767,783 | 1,302,510 | 1.3 M to 1.3 M (-2.49 %) |
| Feb 11 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 23.06 | 33,295 | 767,783 | 1,302,510 | 1.3 M to 1.3 M (-2.49 %) |
| Jan 29 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 23.37 | 900 | 21,033 | 1,335,805 | 1.3 M to 1.3 M (-0.07 %) |
| Jan 29 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 23.01 | 23,805 | 547,753 | 1,336,705 | 1.4 M to 1.3 M (-1.75 %) |
| Jan 23 2020 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 23.04 | 2,000 | 46,080 | 1,360,510 | 1.4 M to 1.4 M (-0.15 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,358 | 0 | 0 | |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | M | 0.00 | 229,357 | 0 | 0 | |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.93 | 1,306 | 27,335 | 1,362,510 | 1.4 M to 1.4 M (-0.10 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 20.39 | 147,528 | 3,008,096 | 1,363,816 | 1.5 M to 1.4 M (-9.76 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Sell | S | 19.34 | 89,698 | 1,734,759 | 1,511,344 | 1.6 M to 1.5 M (-5.60 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,358 | 4,733,949 | 1,601,042 | 1.4 M to 1.6 M (+16.72 %) |
| Dec 09 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | M | 20.64 | 229,357 | 4,733,928 | 1,371,684 | 1.1 M to 1.4 M (+20.08 %) |
| Sep 24 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Gift | G | 0.00 | 5,000 | 0 | 1,142,327 | 1.1 M to 1.1 M (-0.44 %) |
| Sep 24 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Gift | G | 0.00 | 5,000 | 0 | 1,142,327 | 1.1 M to 1.1 M (-0.44 %) |
| Jun 14 2019 | MCRB | Seres Therapeutics ... | Kim Lorence H. | Director | Option Exercise | A | 2.83 | 15,000 | 42,450 | 15,000 | |
| Mar 11 2019 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | A | 20.93 | 211,997 | 4,437,097 | 211,997 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Option Exercise | C | 0.00 | 458 | 0 | 0 | |
| Dec 13 2018 | MRNA | Moderna, Inc. | Kim Lorence H. | Chief Financial Off ... | Buy | C | 0.00 | 458 | 0 | 1,147,327 | 1.1 M to 1.1 M (+0.04 %) |
| Jun 27 2018 | MCRB | Seres Therapeutics ... | Kim Lorence H. | Director | Option Exercise | A | 9.09 | 15,000 | 136,350 | 15,000 | |
| Jun 27 2018 | MCRB | Seres Therapeutics ... | Kim Lorence H. | Director | Option Exercise | A | 9.09 | 15,000 | 136,350 | 15,000 | |
| Jun 21 2017 | MCRB | Seres Therapeutics ... | Kim Lorence H. | Director | Option Exercise | A | 11.21 | 15,000 | 168,150 | 15,000 | |
| Jun 29 2015 | MCRB | Seres Therapeutics ... | Kim Lorence H. | Director | Option Exercise | A | 18.00 | 15,000 | 270,000 | 15,000 |
Page: 1